Bharat Book Bureau Provides the Trending Market Research Report on “Automated Compounding Devices (Oncology) (ACD) - Market Insights, Competitive Landscape and Market Forecast-2025”under Medical Devices Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

Automated Compounding Devices (Oncology) (ACD) -Market Insights, Competitive Landscape and Market Forecast-2025’ report delivers an in-depth understanding of Automated Compounding Devices (Oncology) and the historical and forecasted Automated Compounding Devices (Oncology) market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.

The Automated Compounding Devices (Oncology) Market report provides an overview of Automated Compounding Devices (Oncology), reasons to get ACD (Oncology) as well as its advantages and limitations. Additionally, the report provides insight on the ACD (Oncology) market share of the individual ACD devices, current and forecasted ACD (Oncology) market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Request a free sample copy Automated Compounding Devices (Oncology) (ACD) Market Report @
https://www.bharatbook.com/marketreports/sample/reports/2222989



Automated Compounding Devices (Oncology) Overview
The automated compound devices (ACD) helps in combining several drug solutions to a common container for final administration of the drug within the patient. It helps to eliminate the manual errors and involves the use of computerized algorithms in preparation of the cytotoxic drugs, considering risks associated with the handling of carcinogens for prolonged periods of time, and the extremely personalized treatment in case of cancer patients further increases the chances of an error.

The technology used in ACD comprises of two main methods namely, the gravimetric method and the volumetric methods. Additionally, chemotherapeutic drugs involved are sometimes highly toxic, with a low therapeutic index making it a necessity to prepare the drugs with high precision. The accuracy of these ACD is dependent proportionally on the volume that has to be transferred indicating the higher the volume, more will be the accuracy of the device. Therefore, manufacturers offer a range of volumes that can be transferred, fulfilling the needs of an entire range of customers. The devices are deployed in both hospital settings and pharmacies, measuring powders and liquid component both.

Study Period: 2017–2025
Geography Covered
• The US
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan

List of companies
• Comecer
• Arxium
• Loccioni
• ICU Medical
• Omnicell, Inc
• Baxter Healthcare Corporation
• Grifols International
• S.A., Equashield
• B. Braun Medical Inc.

More companies in the report…
Automated Compounding Devices (Oncology)- Competitive Analysis
This segment of the report provides a brief competitive analysis of Automated Compounding Devices, to help understand the competition in the market. It gives a comparative understanding of the products based on product type.

Automated Compounding Devices (Oncology): Market Analysis
This segment illustrates the market of Automated Compounding Devices (Oncology) across 7MM and how the market is expected to rise in the study period (2017 to 2025), at a significant CAGR.
Automated Compounding Devices (Oncology): Market Segmentation

By Type
• Macro Automated Compounding Systems
• Micro Automated Compounding Systems
• Macro/Micro Automated Compounding Systems

By Technology
• Gravimetric Automated Compounding Systems
• Volumetric Automated Compounding Systems

By End-User
• Hospitals
• Chemotherapy Centers
• Pharmacies

Automated Compounding Devices (Oncology): Market Drivers and Barriers
The report provides insights into the market driving factors and the barriers shaping the Automated Compounding Devices (Oncology) Market.

The growth of ACD market is driven by an increasing need to reduce the medicinal errors, increasing interest of cancer patients in the field of personalized medicines and chemotherapy. The cost incurred at the hospitals per dose is reduced and elimination of contamination while compounding solutions are some major advantages that can help in shaping the ACD market.

However, higher buying and installation cost for the ACD devices are strict regulations pertaining to the ACD are some of the barriers that can obstruct the propelling growth of the ACD market.

Industry Trends
There have been various developments and collaborations in the field of Automated Compounding Devices products. In the late 2018, Arxium launched its cGMP RIVA IV compounding system for hospital and pharmacy use. Fagron acquired JCB Laboratories to reshape the U.S. Sterile Compounding Industry and later in the year 2019, it has announced of opening one of the largest 503B human drug outsourcing facilities in the U.S. in November utilizing automation. In January 2020, Omnicell, Inc. announced that Allegheny General Hospital, Pittsburgh, Pa., part of Allegheny Health Network (AHN), has selected Omnicell’s Central Pharmacy IV Compounding Service, a comprehensive, turnkey approach for insourcing some sterile compounding operations.

KOL- Views
To keep up with the market trends, we take KOLs and SME’s opinion working in Automated Compounding Devices (Oncology) domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Automated Compounding Devices (Oncology) market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report
• The report covers the descriptive overview of Automated Compounding Devices (Oncology), explaining the reasons for replacement, procedure, advantages, and limitations, etc.
• Additionally, an all-inclusive account of the currently available Automated Compounding Devices (Oncology) is provided, which will have an impact on the future market of Automated Compounding Devices (Oncology).
• A detailed review of Automated Compounding Devices (Oncology) market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Automated Compounding Devices (Oncology) market.

Report Highlights
• The report covers descriptive overview of the Automated Compounding Devices (Oncology), explaining its applications, working mechanism, etc.
• The report provides an insight into the patient population eligible for Implantation of Cardiac monitors in the 7 MM, covering the US, EU5 (Germany, Spain, France, Italy, UK) & Japan.
• The report is a comprehensive account of marketed devices present in the Automated Compounding Devices (Oncology) market.
• The report also reviews the detailed global historical and forecasted Automated Compounding Devices (Oncology) devices market including assessing the outreach in 7 MM.
• The report helps in developing business strategies by understanding trends shaping and driving the global Automated Compounding Devices (Oncology) market.

Automated Compounding Devices (Oncology) Report Key Strengths
• 6 Years Forecast
• 7MM Coverage
• Competitive Landscape
• Market Size

Automated Compounding Devices (Oncology) Report Assessment
• Marketed Product profiles
• Key Products and Key Players
• Market Drivers and Barriers
• Market Forecast
• KOL’S views

Key Questions
Market Insights:
• What was the Automated Compounding Devices (Oncology) market share (%) distribution in 2017 and how it will look like in 2025?
• What will be the Automated Compounding Devices (Oncology) total market Size as well as market Size by devices across the 7MM during the forecast period (2017–2025)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Automated Compounding Devices (Oncology) market Size during the forecast period (2017–2025)?
• At what CAGR, the Automated Compounding Devices (Oncology) market is expected to grow in 7MM during the forecast period (2017–2025)?
• What will be the Automated Compounding Devices (Oncology) market outlook across the 7MM during the forecast period (2017–2025)?
• What will be the Automated Compounding Devices (Oncology) market growth till 2025 and what will be the resultant market Size in the year 2025?
• How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?

Competitive Landscape:
• What are the current devices available in the Automated Compounding Devices (Oncology) market?
• What is the Automated Compounding Devices (Oncology) available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
• How many key players are developing Automated Compounding Devices (Oncology)?
• What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Automated Compounding Devices (Oncology)?
• What are the key designations that have been granted for the current Automated Compounding Devices (Oncology)?
• What are the global historical and forecasted market of Automated Compounding Devices (Oncology)?

Browse our full report with Table of Content : https://www.bharatbook.com/marketreports/automated-compounding-devices-oncology-acd-market-insights-competitive-landscape-and-market-forecast-2025/2222989

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]
Website: www.bharatbook.com